G. Nijbroek et al., 15 NOVEL FBN1 MUTATIONS CAUSING MARFAN-SYNDROME DETECTED BY HETERODUPLEX ANALYSIS OF GENOMIC AMPLICONS, American journal of human genetics, 57(1), 1995, pp. 8-21
Mutations in the gene encoding fibrillin-1 (FBN1), a component of the
extracellular microfibril, cause the Marfan syndrome (MFS). This state
ment is supported by the observations that the classic Marfan phenotyp
e cosegregates with intragenic and/or flanking marker alleles in all f
amilies tested and that a significant number of FBN1 mutations have be
en identified in affected individuals. We have now devised a method to
screen the entire coding sequence and flanking splice junctions of FB
N1. On completion for a panel of nine probands with classic MFS, six n
ew mutations were identified that accounted for disease in seven (78%)
of nine patients. Nine additional new mutations have been characteriz
ed in the early stages of a larger screening project. These 15 mutatio
ns were equally distributed throughout the gene and, with one exceptio
n, were specific to single families. One-third of mutations created pr
emature termination codons, and 6 of 15 substituted residues with puta
tive significance for calcium binding to epidermal growth factor (EGF)
-like domains. Mutations causing severe and rapidly progressive diseas
e that presents in the neonatal period can occur in a larger region of
the gene than previously demonstrated, and the nature of the mutation
is as important a determinant as its location, in predisposing to thi
s phenotype.